首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名：Cellr4

缩写：

ISSN：

e-ISSN：2329-7042

IF/分区：0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引109条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Raw Material Specification, Exenatide, 250 μ g/mL [0.03%] 依克那肽原料药质量标准草案250μg/mL
NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium
CellR4-- repair, replacement, regeneration, & reprogramming. 2017;5(2):e2280. DOI: 2017
PHPI, MPBR, Part 2A (Product Code PHPI-A-01, Islets Alone) [0.03%] PHP I，MPBR，第二部分A（产品代码PHPI-A-01，单纯胰岛）
NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium
CellR4-- repair, replacement, regeneration, & reprogramming. 2017;5(2):e2290. DOI: 2017
PHPI, MPBR, Part 2B (Product Code PHPI-L-01 or PHPI-E-01, Islets with Lisofylline or Exenatide) [0.03%] PHP I期，MPBR二期B部分（产品代码：PHP I-L-01或PHP I-E-01，Lisofylline或Exenatide伴随用药）
NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium
CellR4-- repair, replacement, regeneration, & reprogramming. 2017;5(2):e2292. DOI: 2017
Purified Human Pancreatic Islets with Lisofylline, Interim Certificate of Analysis (Product Code PHPI-L-01) [0.03%] 含Lisofylline的纯化人胰岛组织（产品代码PHPI-L-01） interim COA中期分析证书
NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium
CellR4-- repair, replacement, regeneration, & reprogramming. 2017;5(2):e2296. DOI: 2017
Raw Material Specification, Lisofylline, 60 mg/mL [0.03%] 原料药规范，Lisofylline，60毫克/毫升
NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium
CellR4-- repair, replacement, regeneration, & reprogramming. 2017;5(2):e2278. DOI: 2017
PHPI, MPBR, Part 2A (Product Code PHPI-A-01, Islets Alone) [0.03%] PHP I，MPBR，第二部分A（产品代码PHPI-A-01，仅胰岛）
NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium
CellR4-- repair, replacement, regeneration, & reprogramming. 2017;5(2):e2288. DOI: 2017
Purified Human Pancreatic Islets Master Production Batch Record, Part 1 University of Illinois, Chicago & University of Miami (Product Codes PHPI-A-01, PHPI-E-01, PHPI-L-01) [0.03%] 人胰岛纯化主生产工艺记录，第1部分：伊利诺伊大学芝加哥分校和迈阿密大学（产品代码PHPI-A-01、PHPI-E-01、PHPI-L-01）
NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium
CellR4-- repair, replacement, regeneration, & reprogramming. 2017;5(2):e2284. DOI: 2017
Raw Material Specification, Calcium Chloride USP (Dihydrate) [0.03%] 美国药典乳酸钙原料标准（二水合物）
NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium
CellR4-- repair, replacement, regeneration, & reprogramming. 2016;4(3):e1988. DOI: 2016
Raw Material Specification, Povidone Iodine USP, 10 [0.03%] 西药原料 规格10 波维平碘素_USP
NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium
CellR4-- repair, replacement, regeneration, & reprogramming. 2016;4(3):e1974. DOI: 2016
Raw Material Specification, Water for Injection, Sterile, USP [0.03%] 注射用水质量标准(美国药典)
NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee;NIH CIT Consortium
CellR4-- repair, replacement, regeneration, & reprogramming. 2016;4(3):e1982. DOI: 2016